Presynchronization with Gonadotropin-Releasing Hormone Does Not Improve Fertility in Holstein Heifers

Effects of GnRH and hCG administration during early luteal phase on estrous cycle length, expression of estrus and fertility in lactating dairy cows

Our objective was to determine the effects of a single treatment of human chorionic gonadotropin (hCG) or GnRH from d 5 to 7 of the estrous cycle on cycle length, expression of estrus and fertility in lactating dairy cows. Lactating Holstein cows (n = 354) located in Farm 1 and lactating Jersey cows located in Farm 2 (n = 210) detected in estrus by an Automated Activity Monitor (AAM) system from 27 to 50 days in milk (DIM) were randomly assigned to receive one of three treatments from d 5 to 7 of the estrous cycle: control (untreated; CON; Holstein, n = 111; Jersey, n = 66), GnRH (86 μg gonadorelin acetate im; Holstein, n = 116; Jersey, n = 75), or hCG (3,300 IU im; Holstein, n = 127; Jersey, n = 69). Ovaries were scanned with ultrasound in a random subgroup of cows (Holstein/Farm 1, n = 147; Jersey/Farm 2, n = 94) on the day of treatment and 3 or 4 d later to determine ovulation. Estrus was detected after treatment by an AAM, and peak activity and heat index were recorded. A random subgroup of cows observed in estrus after treatment received first AI from 51 to 80 DIM (Holstein, n = 208; Jersey, n = 138). Pregnancy diagnoses were performed by transrectal ultrasonography at 37 ± 3 d post-AI. Holstein and Jersey cows treated with GnRH and hCG had an increased (P < 0.05) ovulatory response compared with controls. Human chorionic gonadotropin decreased (74%; P = 0.05) and GnRH tended to reduce (75%; P = 0.07) the proportion of multiparous Holstein cows returning to estrus compared with CON (86%). Cows treated with hCG had a longer (P < 0.01) estrous cycle length (24.6 ± 0.3 d, Holstein; 23.0 ± 0.3 d, Jersey) compared with CON cows (22.7 ± 0.3 d, Holstein; 21.3 ± 0.3 d Jersey) and GnRH (22.9 ± 0.3 d, Holstein; 21.1 ± 0.3 d Jersey). The percentage of cows with high (≥80) peak activity and heat index did not differ (P > 0.50) between treatments, and milk production did not affect (P > 0.65) the duration of estrus. Pregnancy per AI (P/AI) was not affected by treatments in Holstein (P = 0.93; CON: 34.3%, GnRH: 35.4%, and hCG: 31.5%) and in multiparous Jersey cows (P = 0.35; CON: 34.3%, GnRH: 35.4%, and hCG: 31.5%), but hCG had greater (P = 0.03; 55%) P/AI than GnRH (30.0%) and a trend (P = 0.06) for greater P/AI than CON (33.3%) in primiparous Jersey cows. In summary, inducing the formation of an accessory corpus luteum from d 5 to 7 of the estrous cycle with hCG reduced expression of estrus in multiparous Holstein cows. Moreover, hCG increased estrous cycle length in Holstein and Jersey cows, and it did not affect first service P/AI at 37 ± 3 d post-AI in Holstein and multiparous Jersey lactating cows. However, hCG increased P/AI in primiparous Jersey cows. Future research with a larger number of cows is needed to confirm these intriguing fertility results.

The use of endocrine treatments to improve pregnancy rates in cattle

Reproduction is critical for the success of both dairy and beef cattle production. Inadequate reproduction impairs profitability by compromising production, delaying genetic progress and increasing expenses. A major impediment to the use of artificial insemination (AI) is the ability to detect oestrus for optimum timing of breeding. However, increased understanding of the bovine oestrous cycle has led to the development of reproductive programmes that allow precise synchrony of follicle development, luteal regression and ovulation. The advent of timed-AI protocols revolutionised reproductive management in dairy and beef herds. It allows for AI at a more desired time post partum despite oestrous cyclicity. It also allows for pre-determined re-insemination of cows diagnosed as not pregnant. In subfertile cows, such as the post partum, anoestrous beef cow and the high-producing dairy cow, strategic hormone supplementation has been used to overcome hormone deficiencies and improve pregnancy rates. Several physiological windows have been identified to optimise fertility in synchronisation programmes and they include, but are not limited to, follicle turnover, synchrony of follicular development, length of dominance, progesterone concentrations during development of the ovulatory follicle, luteal regression, peri-ovulatory steroid concentrations, length of pro-oestrus, synchrony of ovulation and AI, and progesterone rise after ovulation.

Application of one injection of prostaglandin F(2alpha) in the five-day Co-Synch+CIDR protocol for estrous synchronization and resynchronization of dairy heifers

The objective was to determine if the 5-d Co-Synch+CIDR (controlled internal drug releasing insert) protocol can be used in dairy heifers for a synchronized timed artificial insemination (TAI) with one injection of PGF(2alpha) for first and second services. In experiment 1, heifers were assigned randomly to receive 1 (n=295) or 2 (n=298) injections of PGF(2alpha) in the 5-d Co-Synch+CIDR protocol. Corpus luteum (CL) regression was measured in one replicate (n=218). No difference in pregnancy per TAI (P/TAI; 46.1 and 48.6%) or CL regression (86.9 and 92.8%) was detected for 1 versus 2 injections of PGF(2alpha), respectively. In experiment 2, nonpregnant heifers (n=86) were assigned to a resynchronized 5-d Co-Synch+CIDR with 1 PGF(2alpha)/TAI or insemination at detected estrus. There was no difference in P/TAI (52.2 and 55%) between groups. In experiment 3, nonpregnant heifers (n=110) were assigned randomly to receive a CIDR (n=54) or no CIDR insert (n=56) in the 5-d Co-Synch protocol for resynchronization of TAI. Pregnancy per TAI was lower without the CIDR device (39.3 vs. 51.8%). In a commercial field evaluation, 416 heifers were synchronized for the first and resynchronized TAI with the 5-d Co-Synch+CIDR protocol with 1 injection of PGF(2alpha). Pregnancy per TAI on d 60 was 58.2 and 47.5% for first and second TAI, respectively; there was a sire effect to the second TAI. In conclusion, the 5-d Co-Synch+CIDR protocol with 1 injection of PGF(2alpha) is an effective reproductive management program for first and second TAI in dairy heifers.

Effect of pretreatment with prostaglandin F2alpha before resynchronization of ovulation on fertility of lactating dairy cows

Our objective was to assess the effect of pretreatment with PGF(2alpha) 12 d before initiation of a protocol for resynchronization of ovulation (Resynch) using an Ovsynch protocol. Lactating Holstein cows diagnosed not pregnant 31 d after a timed artificial insemination (TAI) were randomly assigned to initiate the Resynch protocol 32 d after TAI (n = 255; RES), or receive 25 mg of PGF(2alpha) 34 d after TAI and initiate the Resynch protocol 12 d later at 46 d after TAI (n = 272; PGF+RES). Within each treatment, a subset of cows were examined using transrectal ultrasonography to determine ovulatory response to the first GnRH injection of the Resynch protocols or a blood sample was collected to determine serum progesterone (P(4)) at initiation of the Resynch protocol, or both. Overall, PGF+RES cows had more pregnancies per artificial insemination (P/AI) than RES cows 66 d after TAI (35.2 vs. 25.6%), whereas pregnancy loss from 31 to 66 d after TAI was greater for RES than PGF+RES cows (17.1 vs. 7.6%). Although P/AI was greater for cows with high (>/=1.0 ng/mL) vs. low (<1.0 ng/mL) P(4) at the first GnRH injection of the Resynch protocols, treatment did not affect the proportion of cows with low P(4) at the first GnRH injection of the Resynch protocols. Overall, no effect of treatment on ovulatory response to the first GnRH injection of the Resynch protocols was detected. We conclude that pretreatment with PGF(2alpha) 12 d before initiation of the Resynch protocol increased P/AI 66 d after TAI for cows with serum P(4) concentration >1.0 ng/mL at the first GnRH injection of the Resynch protocol and decreased pregnancy loss from 31 to 66 d after TAI. This modified resynchronization protocol may be a useful strategy for reproductive management of lactating dairy cows.

Assessment of a Practical Method for Identifying Anovular Dairy Cows Synchronized for First Postpartum Timed Artificial Insemination

Our objective was to determine whether a single examination of ovaries using transrectal ultrasonography at the first GnRH injection of a Presynch + Ovsynch protocol is a useful method for assessing cyclicity status and thereby enabling differential management of anovular vs. cyclic cows. Lactating Holstein cows (n = 842) receiving a Presynch + Ovsynch protocol to initiate first postpartum timed artificial insemination (TAI) were used to compare 2 methods for assessing cyclicity status before TAI. For the standard method (using RIA), blood samples were collected at the second PGF2alpha injection of Presynch and the first GnRH injection of Ovsynch, and cows with serum progesterone > or = 1.0 ng/mL in one or both samples were classified as cycling, whereas cows with serum progesterone < 1.0 ng/mL in both samples were classified as anovular. For the practical method, transrectal ultrasonography (U/S) was used to determine the presence or absence of a corpus luteum (CL) at the first GnRH injection of Ovsynch, and cows without CL were classified as anovular, whereas cows with CL were classified as cycling. Statistical agreement (kappa) between the RIA and U/S methods to identify cycling cows was 0.66. Sensitivity, specificity, positive predictive value, and negative predictive value of U/S to identify anovular status were 85.7, 87.7, 64.7, and 95.9%, respectively. We conclude that assessing the presence or absence of CL at the first GnRH injection of a Presynch + Ovsynch protocol using U/S is a reliable and practical method for identifying the cyclicity status of cows before first TAI, but may slightly overestimate the proportion of anovular cows compared with the RIA method.

Efficacy of an injection of dinoprost tromethamine when given subcutaneously on luteal regression in lactating Holstein cows

The objectives of these studies were to evaluate the efficacy of a PGF(2alpha) (PGF) analog given through different routes on causing luteal regression in lactating dairy cows. In Experiment 1, lactating Holstein cows (n=118) at random stages of lactation were blocked by parity and days in milk (DIM) and, within each block, randomly assigned to receive PGF as an intra-muscular (IM) injection in the semimembranous/semitendinous muscle (CON), subcutaneous (SC) injection in the cervical area (SCN), or SC injection in the ischio-rectal fossa (IRF). Blood was sampled at 0, 12, 24, 36, and 48 h after treatment for assessment of progesterone concentration. In Experiment 2, a total of 379 lactating Holstein cows, 46+/-7 DIM, were blocked by DIM and, within each block, randomly assigned to receive treatment similar to CON or IRF groups from Experiment 1. Blood was sampled 0 and 48 h after treatment for assessment of progesterone concentration. Cows were classified as experiencing luteal regression when progesterone concentration was <1.0 ng/mL or <40% of initial concentration (0 h=100%). In Experiment 1, there was no effect of route of PGF treatment on decline in progesterone concentration and on the proportion of cows experiencing luteal regression by 12, 24, 36, and 48 h after treatment. Similarly, in Experiment 2, route of treatment did not affect either the decline in progesterone concentration or the proportion of cows that had luteal regression by 48 h after treatment. Treatment of lactating dairy cows with 25mg of PGF given SC in the ischio-rectal fossa did not affect either the decline in progesterone concentration or the proportion of cows that experienced luteal regression by 12, 24, 36, and 48 h after PGF treatment.